These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34539983)

  • 1. An integrated analysis of enhancer RNAs in glioma and a validation of their prognostic values.
    Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
    Am J Transl Res; 2021; 13(8):8611-8631. PubMed ID: 34539983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
    Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
    BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and Validation of a Novel Prognostic Model for Lower-Grade Glioma Based on Enhancer RNA-Regulated Prognostic Genes.
    Tian W; Yan G; Chen K; Han X; Zhang W; Sun L; Zhang Q; Zhang Y; Li Y; Liu M; Zhang Q
    Front Oncol; 2022; 12():714338. PubMed ID: 35299740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
    Liu J; Li G
    Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A four-enhancer RNA-based prognostic signature for thyroid cancer.
    Liang Y; Zhang Q; Xin T; Zhang DL
    Exp Cell Res; 2022 Mar; 412(2):113023. PubMed ID: 35033555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway.
    Li P; Lin Z; Liu Q; Chen S; Gao X; Guo W; Gong F; Wei J; Lin H
    Front Oncol; 2021; 11():743840. PubMed ID: 34722297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.
    Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W
    Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
    Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma.
    Zheng J; Zhou Z; Qiu Y; Wang M; Yu H; Wu Z; Wang X; Jiang X
    Front Cell Dev Biol; 2021; 9():675555. PubMed ID: 34095147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer.
    Fan S; Wang Z; Zhao L; Zhao C; Yuan D; Wang J
    Front Genet; 2021; 12():676845. PubMed ID: 34267780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
    Chen J; Li Y; Han X; Pan Y; Qian X
    Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
    Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
    Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma.
    Liang Q; Guan G; Li X; Wei C; Wu J; Cheng P; Wu A; Cheng W
    J Transl Med; 2020 Oct; 18(1):378. PubMed ID: 33028341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
    Lei K; Li J; Tu Z; Liu F; Ye M; Wu M; Zhu Y; Luo M; Lin L; Tao C; Huang K; Zhu X
    Front Oncol; 2021; 11():665870. PubMed ID: 34123829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
    Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
    Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a 17-gene signature to improve the survival prediction of gliomas.
    Tong S; Xia M; Xu Y; Sun Q; Ye L; Cai J; Ye Z; Tian D
    Front Immunol; 2022; 13():1000396. PubMed ID: 36248799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel and Robust Prognostic Model for Hepatocellular Carcinoma Based on Enhancer RNAs-Regulated Genes.
    Zhang W; Chen K; Tian W; Zhang Q; Sun L; Wang Y; Liu M; Zhang Q
    Front Oncol; 2022; 12():849242. PubMed ID: 35646665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.